According to SEC filings for the period ending December 2025, CRISPR Therapeutics AG (NASDAQ:CRSP) is held by 451 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 31 Dec, 2025 | 10,522,057 | 735,084 | 7.51% | $551,776,677.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 7,508,178 | 458,033 | 6.50% | $393,728,856.00 |
| Orbis Allan Gray Ltd | 31 Dec, 2025 | 5,950,145 | 968,060 | 19.43% | $312,025,603.00 |
| Capital International Investors | 31 Dec, 2025 | 5,892,745 | 243,487 | 4.31% | $309,015,548.00 |
| STATE STREET CORP | 31 Dec, 2025 | 3,753,440 | -253,793 | -6.33% | $196,830,394.00 |
| GSK plc | 31 Dec, 2025 | 3,220,627 | 3,220,627 | 0.00% | $168,889,680.00 |
| UBS Group AG | 31 Dec, 2025 | 2,524,144 | 185,088 | 7.91% | $132,366,111.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,268,394 | -96,251 | -4.07% | $118,954,581.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,249,223 | 108,053 | 5.05% | $117,970,852.00 |
| SR ONE CAPITAL MANAGEMENT, LP | 31 Dec, 2025 | 2,038,763 | 0 | 0.00% | $106,912,732.00 |
| Sumitomo Mitsui Trust Group, Inc. | 31 Dec, 2025 | 1,958,111 | -205,564 | -9.50% | $102,683,341.00 |
| Amova Asset Management Americas, Inc. | 31 Dec, 2025 | 1,958,111 | -205,564 | -9.50% | $102,605,016.00 |
| FMR LLC | 31 Dec, 2025 | 1,953,957 | 68,294 | 3.62% | $102,465,517.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 1,845,364 | -1,437,220 | -43.78% | $96,771.00 |
| EcoR1 Capital, LLC | 31 Dec, 2025 | 1,389,276 | 0 | 0.00% | $72,853,633.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 1,096,887 | -27,232 | -2.42% | $57,520,761.00 |
| NEA Management Company, LLC | 31 Dec, 2025 | 1,058,570 | 0 | 0.00% | $55,511,411.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 1,030,182 | 44,412 | 4.51% | $54,022,744.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 907,107 | 30,078 | 3.43% | $47,572,612.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 904,600 | 377,600 | 71.65% | $47,437,224.00 |